CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.

Shakib, Pouyan Amini; Ensani, Fereshteh; Abdirad, Afshin; Valizadeh, Bahareh; Seyedmajidi, Maryam; Sum, Shima

Shakib, Pouyan Amini; Ensani, Fereshteh; Abdirad, Afshin; Valizadeh, Bahareh; Seyedmajidi, Maryam; Sum, Shima.

Afiliação

Shakib PA; Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran ; Department of Oral and Maxillofacial Pathology, Tehran University of Medical Sciences, Tehran, Iran.
Ensani F; Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abdirad A; Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Valizadeh B; Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.
Seyedmajidi M; Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.
Sum S; Department of Community Health, Babol University of Medical Sciences, Babol, Iran.

Dent Res J (Isfahan) ; 12(2): 181-6, 2015.

Article em En | MEDLINE | ID: mdl-25878685

Palavras-chave

Antigen; CD24; CD44; carcinoma; immunohistochemistry; squamous cell of head and neck

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Dent Res J (Isfahan) Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google